Diabetic foot infection and its management: A review

Authors

  • Paulson Anette Department of Pharmacy Practice, St. James College of Pharmaceutical Sciences, Chalakudy, Kerala.
  • Kumar K Krishna Department of Pharmacy Practice, St. James College of Pharmaceutical Sciences, Chalakudy, Kerala.
  • L Panayappan Department of Pharmacy Practice, St. James College of Pharmaceutical Sciences, Chalakudy, Kerala.
  • Mathew Leo Department of Pharmacy Practice, St. James College of Pharmaceutical Sciences, Chalakudy, Kerala.

DOI:

https://doi.org/10.30574/gscbps.2018.4.1.0041

Keywords:

Diabetic foot infection (DFI), Diabetes, Infection

Abstract

Diabetic foot infections are common in patients with diabetes which leads to hospitalization and it is the most frequent cause of non-traumatic lower extremity amputation. Diagnosis of foot infections based on clinical signs and symptoms of inflammation. Infected lesion culturing discloses the pathogen and their susceptibilities. The predominant pathogen responsible for infection is gram-positive cocci, especially Staphylococci and also Streptococci. Gram-negative bacilli and anaerobes are mainly found in chronic or previously treated wounds. The infected wounds require antibiotic therapy, the agents, and duration of treatment are predicted based in the severity of infection and initial management of diabetic foot infection should do by empirical therapy which based on the susceptibility data. Preventive measures to control diabetic foot infections are patient education on foot care, glycemic control, use of prescription footwear, intensive care from a podiatrist, and evaluation of surgical interventions indicated. This article explains about Pathophysiology classification, assessing the severity and treatment of diabetic foot infections.

Metrics

Metrics Loading ...

References

Lipsky BA, Bowker JH and Pfeifer MA (2001). Infectious problems of the foot in diabetic patients. In, Eds. The diabetic foot, 6, 467–80.

Reiber GE, Vileikyte L, Boyko EJ, del Aguila M, Smith DG, Lavery LA and Boulton AJ. (1999). Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care, 22, 157-62.

Bagdade JD, Root RK and Bulger RJ. (1974). Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes, 23, 9-15.

Abdulrazak A, Bitar ZI, Al-Shamali AA and Mobasher LA. (2005). Bacteriological study of diabetic foot infections. Diabetes Complications, 19(3), 138-141.

Lipsky BA, Pecoraro RE and Wheat JL. (1990).The diabetic foot: soft tissue and bone infection. Infectious Disease Clinics of North America, 4,409–32.

Sapico FL, Witte JL, Canawati HN, Montgomerie JZ and Bessman AW. (1984). the infected foot of the diabetic patient: quantitative microbiology and analysis of clinical features. Reviews of Infectious Diseases, 6(Suppl 1), 171–6.

Tentolouris N, Jude EB, Smirnof I, Knowles EA and Boulton AJ. (1999). Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic. Diabetic Medicine, 16, 767–71.

Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS and Lipsky BA. (2006). Risk factors for foot infections in individuals with diabetes. Diabetes Care, 29, 1288-93.

Lipsky BA, Peters EJ, Senneville E, BerendtAR,Embil JM, Lavery LA and Jeffcoate WJ. (2012). Expert opinion on the management of infections in the diabetic foot. Diabetes/Metabolism Research and Reviews, 28(suppl 1), 163-178.

Pittet D, Wyssa B, Herter-Clavel C, Kursteiner K, Vaucher J and Lew PD. (1999). Outcome of diabetic foot infections treated conservatively: a retrospective cohort study with long-term follow-up. Archives of Internal Medicine, 159(8), 851-856.

Palestro CJ, Mehta HH, Patel M, Freeman SJ, Harrington WN, Tomas MB, and Marwin SE.(1998). Marrow versus infection in the Charcot joint: indium-111 leukocyte and technetium-99m sulfur colloid scintigraphy. Journal of Nuclear Medicine, 39, 346-350.

Armstrong DG, Lavery LA and Harkless LB. (1998). Validation of a diabetic wound classification system: the contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care, 21, 855–9.

Lipsky BA. (2004). Medical Treatment of Diabetic Foot Infections. Clinical Infectious Diseases, 39, S104–114.

Tan JS, Friedman NM, Hazelton-Miller C, Flanagan JP and File TM Jr. (1996). Can aggressive treatment of diabetic foot infections reduce the need for above-ankle amputation? Clinical Infectious Diseases, 23(2), 286-291.

Schaper NC, Andros G, Apelqvist J Bakker K, Lammer J, Mills JL, Reekers J, Shearman CP and Hinchliffe RJ. (2012). Diagnosis and treatment of peripheral arterial disease in diabetic patients with a foot ulcer. A progress report of the International Working Group on the Diabetic Foot. Diabetes/Metabolism Research and Reviews, 28, 218–224.

Lipsky BA. (2007). Empirical therapy for diabetic foot infections: are there clinical clues to guide antibiotic selection. Clinical Microbiology and Infection, 13, 351–353.

Lipsky BA, Berendt AR, Cornia PB, Pile JC,Peters EJ, Armstrong DG, Deery HG and Embil JM. (2012). Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clinical Infectious Diseases, 54,132–173.

Percival SL, Finnegan S, Donelli G, Vuotto C, Rimmer S and Lipsky BA.(2016). Antiseptics for treating infected wounds: Efficacy on biofilms and effect of pH. Critical Reviews in Microbiology, 42(2), 293-309.

Krause FG, deVries G, Meakin C, Kalla TP, Younger AS.(2009). Outcome of transmetatarsal amputations in diabetics using antibiotic beads. Foot & Ankle International, 30, 486-493.

Boulton AJ, Armstrong DG, Albert SF, Frykberg RG, Hellman R, kirkman MS, Lavery LA, Lemaster JW and Mueller MJ. (2008). Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the american diabetes association, with endorsement by the american association of clinical endocrinologists. Diabetes Care, 31(8), 1679-1685.

Downloads

Published

2021-05-04

How to Cite

Anette, P., Krishna, K. K., Panayappan, L. ., & Leo, M. (2021). Diabetic foot infection and its management: A review. GSC Biological and Pharmaceutical Sciences, 4(1), 19–24. https://doi.org/10.30574/gscbps.2018.4.1.0041

Issue

Section

Original Article